ASAP® Antibacterial Silver Wound Dressing Gel is now cleared as a 510(k) medical device “for use in the management of 1st and 2nd degree burns, stasis…pressure…(and) diabetic ulcers, lacerations, abrasions,  skin tears, surgical incision sites, device insertion site wounds, graft sites and donor sites”; new ASAP product “has been shown (in laboratory tests) to inhibit the growth of…(Staph…E. coli…MRSA and VRE as well as…Candida.” 

SALT LAKE CITY (November 17, 2009)—American Biotech Labs, LLC (ABL), developer of a new class of products based on the company’s patented nano-catalytic SilverSol Technology®, today announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. Clifton Mining Company is a major shareholder in American Biotech Labs.

The FDA 510(k) medical device clearance enables ABL to market its ASAP Antibacterial Silver Gel “for use in the management of 1st and 2nd degree burns, stasis ulcers, pressure ulcers,  diabetic ulcers, lacerations, abrasions,  skin tears, surgical incision sites, device insertion site wounds, graft sites and donor sites.” In addition, according to the draft package insert, the new product “has in laboratory tests been shown to inhibit the growth of microorganisms such as (Staph…E. coli…MRSA and VRE as well as fungi such as Candida albicans.” 

The product utilizes ABL’s innovative SilverSol Technology®, which has garnered multiple patents in the U.S. and several countries throughout the world, including a broad-use patent that provides the company with exclusive rights to use its silver-based products to combat many of the world’s most destructive pathogens. ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens. Information about these studies is available at research section of the ABL Website.

“The FDA’s decision to grant clearance for the ASAP Antibacterial Silver Wound Dressing Gel as a prescription device is an extraordinary validation for our company and its patented processes and uses,” said Dr. William Moeller, a Managing Director of American Biotech Labs. “This is a major step forward in our mission of using our products to improve lives by combating many of the world’s most deadly pathogens.”

This is the second ABL product to obtain FDA clearance; in April the company’s ASAP Wound Dressing Gel received clearance as a 510(k) over-the-counter medical device. Ask the Pharmacist for ASAP-Silver Gel.

Hi, my name is Robert Brooks Manfull. My father was Kenneth Brooks Manfull from Augusta, Ohio. He was named after his uncle The Honorable Congressman Thomas Brooks Fletcher who I never met as he died before I was born.

His death,in Washington DC,was not long after he sent a letter to my dad, who aspired to follow in his uncle's foot steps and leave the farm to be a serve in congress. In that letter he told dad to "stay on the farm". " This [ Washington] is not a good place to be",he told dad. My dad did go to Washington one time, but only to investigate his uncle's death he had reason to believe was not of natural causes.

I was born in 1948 about 21 days before Israel became a state. The cartoon my 6 and 12 year old brothers would have seen on a TV or more likely at the Motion Picture Theater, is posted for you to now view and pontificate if we are all brighter and better educated or stupider less informed than our great grandparents were.

Adobe Flash Player not installed or older than 9.0.115!